Related Experiment Video
Updated: May 5, 2026
10:25
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
9.4K
What else should hemostatic materials do beyond hemostasis: A review.
Xinran Yang1,2,3, Xiudan Wang1,2,3, Xing Gao1,4
1Institution of Disaster and Emergency Medicine, Tianjin University, Tianjin 300072, China.
Materials Today. Bio
|March 18, 2024
Summary
Advanced hemostatic materials are crucial for managing severe blood loss in emergencies. This review explores modifications to enhance hemostatic materials for better wound management and patient outcomes.
Area of Science:
- Biomaterials Science
- Emergency Medicine
- Surgical Innovation
Background:
- Massive blood loss from injuries is a primary cause of prehospital mortality during emergencies and disasters.
- Current hemostatic materials aim for rapid bleeding control but often lack versatility for diverse clinical needs.
Purpose of the Study:
- To review strategies for modifying hemostatic materials to meet varied application requirements beyond basic hemostasis.
- To discuss challenges in practical hemostatic material use and recent research advancements.
Main Methods:
- Literature review of existing hemostatic materials and their functional modifications.
- Analysis of strategies for enhancing hemostatic material performance in different wound scenarios.
Main Results:
- Hemostatic materials require functional adaptations for effective positioning, stability under pressure, ease of removal, and sustained therapeutic effects (e.g., antibacterial, tissue repair).
- Modifications address challenges like deep wound application, resistance to wound movement, and integration with subsequent treatments.
Conclusions:
- Future hemostatic materials need to incorporate multifunctional properties tailored to specific clinical scenarios.
- This review provides insights for developing more comprehensive and practical hemostatic solutions for severe bleeding.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:05Introduction to Hemostasis
14.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K
01:09Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K